$13.91
2.88% yesterday
Nasdaq, Aug 12, 10:00 pm CET
ISIN
IL0011794802
Symbol
CLBT
Industry

Cellebrite DI Stock price

$13.91
-0.71 4.86% 1M
-11.01 44.18% 6M
-8.12 36.86% YTD
+0.57 4.27% 1Y
+8.57 160.49% 3Y
+4.25 44.00% 5Y
+4.25 44.00% 10Y
+4.25 44.00% 20Y
Nasdaq, Closing price Tue, Aug 12 2025
+0.39 2.88%
ISIN
IL0011794802
Symbol
CLBT
Industry

Key metrics

Basic
Market capitalization
$3.2b
Enterprise Value
$2.8b
Net debt
positive
Cash
$409.5m
Shares outstanding
239.5m
Valuation (TTM | estimate)
P/E
negative | 28.9
P/S
7.7 | 6.7
EV/Sales
6.8 | 5.8
EV/FCF
21.4
P/B
8.9
Financial Health
Equity Ratio
48.7%
Return on Equity
-84.2%
ROCE
14.2%
ROIC
369.4%
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$419.2m | $484.5m
EBITDA
$70.5m | $119.9m
EBIT
$59.9m | $111.6m
Net Income
$-194.2m | $112.1m
Free Cash Flow
$132.2m
Growth (TTM | estimate)
Revenue
22.1% | 20.8%
EBITDA
34.0% | 77.7%
EBIT
41.5% | 96.0%
Net Income
-73.6% | 139.6%
Free Cash Flow
45.8%
Margin (TTM | estimate)
Gross
84.1%
EBITDA
16.8% | 24.8%
EBIT
14.3%
Net
-46.3% | 23.1%
Free Cash Flow
31.5%
More
EPS
$-0.8
FCF per Share
$0.6
Short interest
2.9%
Employees
1k
Rev per Employee
$400.0k
Show more

Is Cellebrite DI a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,027 stocks worldwide.

Cellebrite DI Stock Analysis

Unlock Scores for Free

Analyst Opinions

14 Analysts have issued a Cellebrite DI forecast:

13x Buy
93%
1x Hold
7%

Analyst Opinions

14 Analysts have issued a Cellebrite DI forecast:

Buy
93%
Hold
7%

Financial data from Cellebrite DI

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
419 419
22% 22%
100%
- Direct Costs 67 67
24% 24%
16%
352 352
22% 22%
84%
- Selling and Administrative Expenses 190 190
18% 18%
45%
- Research and Development Expense 103 103
19% 19%
24%
70 70
34% 34%
17%
- Depreciation and Amortization 11 11
3% 3%
3%
EBIT (Operating Income) EBIT 60 60
42% 42%
14%
Net Profit -194 -194
74% 74%
-46%

In millions USD.

Don't miss a Thing! We will send you all news about Cellebrite DI directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Cellebrite DI Stock News

Neutral
GlobeNewsWire
21 days ago
TYSONS CORNER, Va., July 23, 2025 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ: CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced the U.S. Department of Justice (DOJ) will serve as the official sponsoring agency for the platform's pursuit of a FedRAMP High authorization.
Neutral
GlobeNewsWire
about one month ago
TYSONS CORNER, Va. and PETAH TIKVA, Israel, July 08, 2025 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ: CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced that David Barter, a proven finance executive with extensive public company CFO experience in technology and software, has been appointed CFO, effective immediately.
Neutral
GlobeNewsWire
about 2 months ago
TYSONS CORNER, Va., June 24, 2025 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ: CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced the expansion of its relationship with the National Center for Missing and Exploited Children (NCMEC) that will help speed up investigations involving crimes against children. NCMEC's CyberTipline hash val...
More Cellebrite DI News

Company Profile

Cellebrite DI Ltd. engages in the provision of digital investigative solutions for the public and private sectors, empowering organizations in mastering the complexities of legally sanctioned digital investigations by streamlining intelligence processes. Its services include training and advisory, value realization, advanced services, and technical customer support. The firm also offers software solutions and analytic tools designed to accelerate digital investigations and address the growing complexity of handling crime and security challenges in the digital era. The company was founded on April 13, 1999 and is headquartered in Petach Tikva, Israel.

Head office Israel
CEO Thomas Hogan
Employees 1,008
Founded 1999
Website www.cellebrite.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today